Preferred Label : Tolvaptan;

MeSH definition : A benzazepine derivative and selective VASOPRESSIN V2 RECEPTOR antagonist that is used to treat euvolemic and hypervolemic HYPONATREMIA. It is also used in the treatment of rapidly progressing AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE to slow the rate of cyst development and renal insufficiency.;

MeSH synonym : 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine;

MeSH hyponym : OPC-41061; OPC41061;

MeSH CAS label : Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-;

MeSH Related Number : 150683-30-0 (Tolvaptan);

Wikipedia link : https://en.wikipedia.org/wiki/Tolvaptan;

UNII : 21G72T1950;

Details


Main resources

You can consult :

A benzazepine derivative and selective VASOPRESSIN V2 RECEPTOR antagonist that is used to treat euvolemic and hypervolemic HYPONATREMIA. It is also used in the treatment of rapidly progressing AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE to slow the rate of cyst development and renal insufficiency.

https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout

---
https://www.has-sante.fr/jcms/p_3080482/fr/jinarc
2019
false
true
false
false
France
tolvaptan
polycystic kidney, autosomal dominant
adult
renal insufficiency, chronic
Antidiuretic Hormone Receptor Antagonists
Tolvaptan
insurance, health, reimbursement
treatment outcome
evaluation of the transparency committee

---
https://www.inesss.qc.ca/index.php?id=72&DemandePluginController%5Buid%5D=4469&DemandePluginController%5Bonglet%5D=2&DemandePluginController%5BbackUrl%5D=%252Findex.php%253Fid%253D72%2526no_cache%253D1%2526DemandePluginController%25255Buid%25255D%253D4496%2526DemandePluginController%25255Bonglet%25255D%253D2&cHash=5edf4c69d7bf773ddc3ff1c71124ba6c
2018
false
false
false
Canada
French
drug evaluation
benzazepines
Tolvaptan

---
https://www.has-sante.fr/portail/jcms/c_2876340/fr/samsca
https://www.has-sante.fr/portail/jcms/c_2876340/fr/samsca-tolvaptan-antagoniste-de-la-vasopressine
2018
false
France
French
Antidiuretic Hormone Receptor Antagonists
Antidiuretic Hormone Receptor Antagonists
chronic disease
guidelines for drug use
Vasopressin V2 Receptor
insurance, health, reimbursement
tolvaptan
benzazepines
receptors, vasopressin
hyponatremia
inappropriate adh syndrome
adult
administration, oral
treatment outcome
benzazepines
evaluation of the transparency committee
Tolvaptan
Tolvaptan

---
http://www.has-sante.fr/portail/jcms/c_2589169/fr/jinarc
http://www.has-sante.fr/portail/jcms/c_2589169/fr/jinarc-tolvaptan-antagoniste-de-la-vasopressine
2015
false
false
false
France
French
tolvaptan
treatment outcome
polycystic kidney, autosomal dominant
continuity of patient care
administration, oral
Antidiuretic Hormone Receptor Antagonists
Vasopressin V2 Receptor
Product containing precisely tolvaptan 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely tolvaptan 30 milligram/1 each conventional release oral tablet (clinical drug)
evaluation of the transparency committee
insurance, health, reimbursement
guidelines for drug use
receptors, vasopressin
benzazepines
Tolvaptan

---
https://www.ema.europa.eu/medicines/human/EPAR/Jinarc
2015
false
false
false
United Kingdom
French
English
summary of product characteristics
package leaflet
drug evaluation
syndication feed
tolvaptan
drug approval
europe
treatment outcome
polycystic kidney, autosomal dominant
continuity of patient care
administration, oral
product surveillance, postmarketing
risk management
Antidiuretic Hormone Receptor Antagonists
Antidiuretic Hormone Receptor Antagonists
drug interactions
pregnancy
breast feeding
Vasopressin V2 Receptor
drug evaluation, preclinical
Product containing precisely tolvaptan 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely tolvaptan 30 milligram/1 each conventional release oral tablet (clinical drug)
receptors, vasopressin
benzazepines
benzazepines
Tolvaptan
Tolvaptan

---
https://www.canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2013/23671a-fra.php
https://www.canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2013/23679a-fra.php
https://www.canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2013/23671a-eng.php
https://www.canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2013/23679a-eng.php
2013
Canada
French
tolvaptan
hyponatremia
Chemical and Drug Induced Liver Injury
pharmacovigilance note
benzazepines
polycystic kidney, autosomal dominant
Tolvaptan

---
https://www.ema.europa.eu/medicines/human/EPAR/Samsca
2012
false
United Kingdom
French
English
Antidiuretic Hormone Receptor Antagonists
Antidiuretic Hormone Receptor Antagonists
syndication feed
benzazepines
treatment outcome
drug approval
receptors, vasopressin
benzazepines
adult
tablets
administration, oral
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug labeling
hyponatremia
tolvaptan
Vasopressin V2 Receptor
package leaflet
summary of product characteristics
drug evaluation
Tolvaptan
Tolvaptan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63790853
2012
France
summary of product characteristics
package leaflet
tablets
Tolvaptan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67412139
2012
France
summary of product characteristics
package leaflet
tablets
Tolvaptan

---
Summary Basis of Decision (SBD) for SAMSCA - Tolvaptan, 15 mg, 30 mg, and 60 mg tablets
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00132
2011
false
Canada
English
French
Antidiuretic Hormone Receptor Antagonists
Antidiuretic Hormone Receptor Antagonists
drug evaluation
benzazepines
benzazepines
administration, oral
drug approval
treatment outcome
risk assessment
tolvaptan
receptors, vasopressin
Vasopressin V2 Receptor
hyponatremia
multicenter studies as topic
double-blind method
Tolvaptan
Tolvaptan

---
http://www.has-sante.fr/portail/jcms/c_983200/samsca-tolvaptan-antagoniste-de-la-vasopressine
2010
false
France
French
Antidiuretic Hormone Receptor Antagonists
Antidiuretic Hormone Receptor Antagonists
Vasopressin V2 Receptor
benzazepines
receptors, vasopressin
hyponatremia
tolvaptan
adult
insurance, health, reimbursement
continuity of patient care
inappropriate adh syndrome
aged
treatment outcome
benzazepines
evaluation of the transparency committee
guidelines for drug use
Tolvaptan
Tolvaptan

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/samsca_-_ct-7798.pdf
http://www.has-sante.fr/portail/jcms/c_964925/samsca
2010
false
France
French
Antidiuretic Hormone Receptor Antagonists
Antidiuretic Hormone Receptor Antagonists
Vasopressin V2 Receptor
insurance, health, reimbursement
tolvaptan
benzazepines
receptors, vasopressin
hyponatremia
inappropriate adh syndrome
adult
administration, oral
treatment outcome
benzazepines
evaluation of the transparency committee
Tolvaptan
Tolvaptan

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.